Treace Medical Concepts TMCI Income Statement (2020-2026)

NASDAQ TMCI
$4.53 -0.10 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Treace Medical Concepts Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Treace Medical Concepts reported revenue of $45.38M and net income of -$15.90M for the quarter ended Jun 2026, down 4.2% year over year. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
21.62M33.44M29.05M29.97M33.05M49.77M42.20M41.95M40.76M62.21M51.11M44.45M45.09M68.71M52.57M47.39M50.21M62.52M47.20M45.38M
Cost of RevenueCost of Rev
4.25M5.37M5.13M5.29M6.09M9.02M8.04M7.67M8.00M11.47M10.13M8.78M8.95M13.23M10.68M9.63M10.51M12.12M9.79M9.77M
Gross Profit
17.37M28.07M23.92M24.68M26.96M40.75M34.16M34.28M32.76M50.74M40.98M35.67M36.13M55.48M41.89M37.75M39.71M50.40M37.41M35.61M
Operating items
Research & DevelopmentR&D
15.98M23.26M22.30M26.61M25.57M30.09M33.66M33.77M33.54M39.92M40.33M37.68M32.77M36.86M36.12M33.08M34.42M37.25M33.77M30.94M
Selling, General & AdministrativeSG&A
4.31M7.03M6.66M7.01M8.92M10.41M10.87M10.03M12.69M13.45M14.36M14.22M13.53M13.61M15.79M16.14M16.28M14.53M16.18M15.25M
Other Operating ExpensesOther Opex
2.54M3.38M0.00M-0.00M-0.04M-0.36M0.13M0.10M0.02M0.10M0.07M0.11M0.02M0.12M0.13M0.12M0.09M0.09M0.28M0.20M
Operating ExpensesOpex
22.83M33.67M32.01M36.61M38.28M44.24M47.93M47.33M50.58M57.52M59.95M57.06M51.27M55.68M57.48M54.73M55.38M56.32M54.57M50.56M
Operating IncomeOp. Inc
-5.46M-5.60M-8.10M-11.93M-11.32M-3.50M-13.78M-13.05M-17.82M-6.78M-18.97M-21.38M-15.13M-0.20M-15.58M-16.97M-15.68M-5.92M-17.17M-14.96M
EBIT
-5.46M-5.60M-8.10M-11.93M-11.32M-3.50M-13.78M-13.05M-17.82M-6.78M-18.97M-21.38M-15.13M-0.20M-15.58M-16.97M-15.68M-5.92M-17.17M-14.96M
Non-operating items
Non Operating Interest Expenses
0.96M1.03M0.95M0.95M1.19M1.31M1.28M1.28M1.30M1.30M1.32M1.31M1.31M1.31M1.31M1.32M1.34M1.35M1.57M1.56M
Non Operating Investment IncomeNon-Op. Investment Inc.
-0.03M-0.03M-0.16M0.07M0.31M-0.09M-0.10M0.22M-0.09M-0.04M-0.01M0.03M-0.01M-0.10M-0.03M
Interest & Investment IncomeInt & Inv Inc
0.01M0.01M0.01M0.13M0.42M0.75M1.48M1.97M1.57M1.71M1.53M1.38M1.07M0.90M0.84M0.78M0.63M0.53M0.50M0.45M
Other Non Operating IncomeOther Non Op Inc.
-0.96M-1.02M-0.94M-5.30M-0.81M-0.92M0.32M0.78M0.30M0.50M0.29M0.18M-0.23M-0.30M-0.34M-0.42M-0.61M2.70M-0.79M-0.92M
Net income details
EBT
-6.42M-6.62M-9.04M-12.75M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.62M-16.05M-17.52M-16.38M-6.75M-18.24M-16.07M
Profit After TaxPAT
-6.42M-6.82M-9.04M-17.23M-12.13M-4.44M-13.45M-12.27M-17.52M-6.16M-18.68M-21.21M-15.36M-0.57M-15.92M-17.41M-16.29M-9.40M-17.96M-15.90M
Income from Continuing OperationsIncome (Continuing)
-6.42M-6.62M-9.04M-12.75M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.62M-16.05M-17.52M-16.38M-6.75M-18.24M-16.07M
Consolidated Net IncomeConsol Net Inc.
-6.42M-6.62M-9.04M-12.75M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.62M-16.05M-17.52M-16.38M-6.75M-18.24M-16.07M
Income towards Parent CompanyParent Net Inc
-6.42M-6.62M-9.04M-12.75M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.62M-16.05M-17.52M-16.38M-6.75M-18.24M-16.07M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-6.42M-6.62M-9.04M-17.23M-12.13M-4.41M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.62M-16.05M-17.52M-16.38M-6.75M-18.24M-16.07M
Additional items
EPS (Basic)
-0.12-0.14-0.16-0.31-0.22-0.08-0.23-0.20-0.28-0.10-0.30-0.34-0.25-0.01-0.26-0.28-0.26-0.11-0.28-0.25
EPS (Diluted)
-0.12-0.14-0.16-0.31-0.22-0.08-0.23-0.20-0.28-0.10-0.30-0.34-0.25-0.01-0.26-0.28-0.26-0.11-0.28-0.25
Shares Outstanding
52.77M48.42M54.83M55.31M55.43M55.28M58.72M61.38M61.56M60.85M61.79M62.08M62.23M62.11M62.66M63.01M63.52M63.27M64.59M65.05M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
52.77M48.42M54.83M55.31M55.43M55.28M58.72M61.38M61.56M60.85M61.79M62.08M62.23M62.11M62.66M63.01M63.52M63.27M64.59M65.05M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
82.80M82.80M82.80M82.80M82.80M55.63M61.28M61.53M61.61M61.75M61.93M62.18M62.28M62.62M62.90M63.17M63.72M64.59M64.87M65.03M
EBITDA
-5.46M-5.60M-8.10M-11.93M-11.32M-3.50M-13.78M-13.05M-17.82M-6.78M-18.97M-21.38M-15.13M-0.20M-15.58M-16.97M-15.68M-5.92M-17.17M-14.96M
Interest ExpensesInt Expense
0.96M1.03M0.95M0.95M1.19M1.31M1.28M1.28M1.30M1.30M1.32M1.31M1.31M1.31M1.31M1.32M1.34M1.35M1.57M1.56M